Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...
Hims & Hers Health Inc. shares surged as much as 18% and are on track to close at fresh record after Hunterbrook Media said the company is poised to be a major beneficiary of President-elect Donald ...
After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.
Maryland scholars on Monday alternately described President-elect Donald Trump’s pick to lead the U.S. Food and Drug ...
Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...
STAT reporters reached out to key figures in biotech, pharma, and medical devices to find out what they think about President ...
President-elect Donald Trump’s proposed lineup to lead the government’s health agencies look like bad news for vaccine ...
President-elect Trump announced on Friday that he is nominating Dr. Marty Makary, a Johns Hopkins School of Medicine ...
Makary and Weldon, who have criticized the agencies they may soon run, were joined by Janette Nesheiwat, Trump’s pick to be ...
President-elect Trump has picked Marty Makary, a Johns Hopkins’s surgeon who has espoused contrarian views about the COVID-19 ...
President-elect Donald Trump on Friday nominated Dr. Marty Makary, a pancreatic surgeon at Johns Hopkins University, as ...
(NEW YORK) — President Donald Trump said he wants Marty Makary, a Johns Hopkins surgeon and author who argued against pandemic lockdowns, to lead the U.S. Food and Drug Administration.